Bandaram Pharma Packtech Ltd
Fundamental Score
Bandaram Pharma Packtech Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of BANDARAM across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Revenue Growth (92.97%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Balanced Promoter Holding (62.62%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
10 factors identified
Below-Average Return on Equity (7.94%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.67%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 259.20x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-91.04%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Elevated Debt Levels (D/E: 1.71)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Weak Interest Coverage (1.68x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
High Debt-to-Equity Ratio
Observation: Elevated financial risk due to high leverage.
Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Bandaram Pharma Packtech Ltd
About BANDARAM
Business Overview
Bandaram Pharma Packtech Limited operates in the paper industry in India. The company engages in the processing and supply of recycled paper; and trading of paper board. It also supplies various categories of recycled paper to small and medium size paper mills. The company was formerly known as Shiva Medicare Limited and changed its name to Bandaram Pharma Packtech Limited in March 2022. Bandaram Pharma Packtech Limited was incorporated in 1993 and is based in Bengaluru, India.
Company Details
Key Leadership
Corporate Events
BANDARAM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Bandaram Pharma Packtech Ltd (BANDARAM)?
As of 30 Jan 2026, 01:35 pm IST, Bandaram Pharma Packtech Ltd (BANDARAM) is currently trading at ₹26.00. The stock has a market capitalization of ₹57.02 (Cr).
Is BANDARAM share price Overvalued or Undervalued?
BANDARAM is currently trading at a P/E ratio of 259.20x, compared to the industry average of 39.28x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Bandaram Pharma Packtech Ltd share price?
Key factors influencing BANDARAM's price include its quarterly earnings growth (Sales Growth: 92.97%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Bandaram Pharma Packtech Ltd a good stock for long-term investment?
Bandaram Pharma Packtech Ltd shows a 5-year Profit Growth of N/A% and an ROE of 7.94%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.71 before investing.
How does Bandaram Pharma Packtech Ltd compare with its industry peers?
Bandaram Pharma Packtech Ltd competes with major peers in the Healthcare Service Provider. Investors should compare BANDARAM's P/E of 259.20x and ROE of 7.94% against the industry averages to determine its competitive standing.
What is the P/E ratio of BANDARAM and what does it mean?
BANDARAM has a P/E ratio of 259.20x compared to the industry average of 39.28x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹259 for every ₹1 of annual earnings.
How is BANDARAM performing according to Bull Run's analysis?
BANDARAM has a Bull Run fundamental score of N/A/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does BANDARAM belong to?
BANDARAM operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Bandaram Pharma Packtech Ltd.
What is Return on Equity (ROE) and why is it important for BANDARAM?
BANDARAM has an ROE of 7.94%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Bandaram Pharma Packtech Ltd generates profits from shareholders' equity.
How is BANDARAM's debt-to-equity ratio and what does it indicate?
BANDARAM has a debt-to-equity ratio of 1.71, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is BANDARAM's dividend yield and is it a good dividend stock?
BANDARAM offers a dividend yield of 0.21%, which means you receive ₹0.21 annual dividend for every ₹100 invested.
How has BANDARAM grown over the past 5 years?
BANDARAM has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in BANDARAM and why does it matter?
Promoters hold 62.62% of BANDARAM shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is BANDARAM's market capitalization category?
BANDARAM has a market capitalization of ₹57 crores, placing it in the Small-cap category.
How volatile is BANDARAM stock?
BANDARAM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for BANDARAM?
BANDARAM has a 52-week high of ₹N/A and low of ₹N/A.
What is BANDARAM's operating profit margin trend?
BANDARAM has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is BANDARAM's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 92.97% and YoY Profit Growth of -91.04%.
What is the institutional holding pattern in BANDARAM?
BANDARAM has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.